International Stem Cell (OTC:ISCO) said on Wednesday that its chairman Kenneth Aldrich will present at the Rodman & Renshaw Annual Global Investment Conference next week.
The conference, scheduled to take place on Monday, September 12, will be held at the Waldorf Astoria Hotel in New York City at 11:40 a.m.
After the conference, a link to the presentation will also be posted to International Stem Cell’s website, at www.intlstemcell.com.
International Stem Cell is a biotechnology company with a focus on the therapeutic applications of human parthenogentic stem cells, and the development and commercialization of cell-based research and cosmetic products.
The company has developed a method to derive stem cells similar to embryonic stem cells without the need for fertilized eggs, called parthenogenesis.
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment